Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Tumor Biomarker Test Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance
  • 2.1.1 Product Type Market Performance (Volume)
  • 2.1.2 Product Type Market Performance (Value)
• 2.2 China Tumor Biomarker Test Market Performance
• 2.3 USA Tumor Biomarker Test Market Performance
• 2.4 Europe Tumor Biomarker Test Market Performance
• 2.5 Japan Tumor Biomarker Test Market Performance
• 2.6 Korea Tumor Biomarker Test Market Performance
• 2.7 India Tumor Biomarker Test Market Performance
• 2.8 Southeast Asia Tumor Biomarker Test Market Performance
• 2.9 South America Tumor Biomarker Test Market Performance

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
• 3.2 China Tumor Biomarker Test Market Performance (Volume)
• 3.3 USA Tumor Biomarker Test Market Performance (Volume)
• 3.4 Europe Tumor Biomarker Test Market Performance (Volume)
• 3.5 Japan Tumor Biomarker Test Market Performance (Volume)
• 3.6 Korea Tumor Biomarker Test Market Performance (Volume)
• 3.7 India Tumor Biomarker Test Market Performance (Volume)
• 3.8 Southeast Asia Tumor Biomarker Test Market Performance (Volume)
• 3.9 South America Tumor Biomarker Test Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Abbott Laboratories, Inc.
  • 4.1.1 Abbott Laboratories, Inc. Profiles
  • 4.1.2 Abbott Laboratories, Inc. Product Information
  • 4.1.3 Abbott Laboratories, Inc. Tumor Biomarker Test Business Performance
  • 4.1.4 Abbott Laboratories, Inc. Tumor Biomarker Test Business Development and Market Status
• 4.2 Agilent Technologies
  • 4.2.1 Agilent Technologies Profiles
  • 4.2.2 Agilent Technologies Product Information
  • 4.2.3 Agilent Technologies Tumor Biomarker Test Business Performance
  • 4.2.4 Agilent Technologies Tumor Biomarker Test Business Development and Market Status
• 4.3 AstraZeneca
  • 4.3.1 AstraZeneca Profiles
  • 4.3.2 AstraZeneca Product Information
  • 4.3.3 AstraZeneca Tumor Biomarker Test Business Performance
  • 4.3.4 AstraZeneca Tumor Biomarker Test Business Development and Market Status
• 4.4 Becton Dickinson & Co.
  • 4.4.1 Becton Dickinson & Co. Profiles
  • 4.4.2 Becton Dickinson & Co. Product Information
  • 4.4.3 Becton Dickinson & Co. Tumor Biomarker Test Business Performance
  • 4.4.4 Becton Dickinson & Co. Tumor Biomarker Test Business Development and Market Status
• 4.5 Biocept Inc.
  • 4.5.1 Biocept Inc. Profiles
  • 4.5.2 Biocept Inc. Product Information
  • 4.5.3 Biocept Inc. Tumor Biomarker Test Business Performance
  • 4.5.4 Biocept Inc. Tumor Biomarker Test Business Development and Market Status
• 4.6 Cancer Genetics Inc.
  • 4.6.1 Cancer Genetics Inc. Profiles
  • 4.6.2 Cancer Genetics Inc. Product Information
  • 4.6.3 Cancer Genetics Inc. Tumor Biomarker Test Business Performance
  • 4.6.4 Cancer Genetics Inc. Tumor Biomarker Test Business Development and Market Status
• 4.7 Danaher Corporation
  • 4.7.1 Danaher Corporation Profiles
  • 4.7.2 Danaher Corporation Product Information
  • 4.7.3 Danaher Corporation Tumor Biomarker Test Business Performance
  • 4.7.4 Danaher Corporation Tumor Biomarker Test Business Development and Market Status
• 4.8 Foundation Medicine Inc.
  • 4.8.1 Foundation Medicine Inc. Profiles
  • 4.8.2 Foundation Medicine Inc. Product Information
  • 4.8.3 Foundation Medicine Inc. Tumor Biomarker Test Business Performance
  • 4.8.4 Foundation Medicine Inc. Tumor Biomarker Test Business Development and Market Status
• 4.9 Illumina Inc.
  • 4.9.1 Illumina Inc. Profiles
  • 4.9.2 Illumina Inc. Product Information
  • 4.9.3 Illumina Inc. Tumor Biomarker Test Business Performance
  • 4.9.4 Illumina Inc. Tumor Biomarker Test Business Development and Market Status
• 4.10 LabCorp Of America Holdings
  • 4.10.1 LabCorp Of America Holdings Profiles
  • 4.10.2 LabCorp Of America Holdings Product Information
  • 4.10.3 LabCorp Of America Holdings Tumor Biomarker Test Business Performance
  • 4.10.4 LabCorp Of America Holdings Tumor Biomarker Test Business Development and Market Status
• 4.11 Luminex Corporation
• 4.12 Myriad Genetics Inc.
• 4.13 AstraZeneca
• 4.20 LabCorp Of America Holdings

5 Market Performance for Manufacturers

• 5.1 Global Tumor Biomarker Test Production (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Global Tumor Biomarker Test Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Global Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Global Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Global Tumor Biomarker Test Market Performance (Production Point)

• 6.1 Global Tumor Biomarker Test Production (K Units) and Market Share by Regions 2013-2018
• 6.2 Global Tumor Biomarker Test Revenue (M USD) and Market Share by Regions 2013-2018
• 6.3 Global Tumor Biomarker Test Price (USD/Unit) by Regions 2013-2018
• 6.4 Global Tumor Biomarker Test Gross Margin by Regions 2013-2018

7 Development Trend for Regions (Production Point)

• 7.1 Global Tumor Biomarker Test Production (K Units), Revenue (&$B$8&) and Growth Rate 2013-2018
• 7.2 China Tumor Biomarker Test Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.3 USA Tumor Biomarker Test Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.4 Europe Tumor Biomarker Test Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.5 Japan Tumor Biomarker Test Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.6 Korea Tumor Biomarker Test Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.7 India Tumor Biomarker Test Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.8 Southeast Asia Tumor Biomarker Test Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.9 South America Tumor Biomarker Test Production (K Units), Revenue (M USD) and Growth Rate 2013-2018

8 Global Tumor Biomarker Test Market Performance (Consumption Point)

• 8.1 Global Tumor Biomarker Test Consumption and Market Share by Regions 2013-2018
• 8.2 Global Tumor Biomarker Test Consumption Value and Market Share by Regions 2013-2018
• 8.3 Global Tumor Biomarker Test Price (USD/Unit) by Regions 2013-2018

9 Development Trend for Regions (Sales Point)

• 9.1 Global Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.2 China Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.3 USA Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.4 Europe Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.5 Japan Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.6 Korea Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.7 India Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.8 Southeast Asia Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.9 South America Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018

10 Upstream Source, Technology and Cost

• 10.1 Upstream Source
• 10.2 Technology
• 10.3 Cost

11 Channel Analysis

• 11.1 Market Channel
• 11.2 Distributors

12 Consumer Analysis

• 12.1 Lung cancer Industry
• 12.2 Breast cancer Industry
• 12.3 Colorectal Industry
• 12.4 Prostate Cancer Industry

13 Market Forecast 2019-2024

• 13.1 Production (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 13.1.1 Global Tumor Biomarker Test Production (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 13.1.2 Global Tumor Biomarker Test Production (K Units) and Growth Rate 2019-2024
  • 13.1.3 China Tumor Biomarker Test Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.4 USA Tumor Biomarker Test Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.5 Europe Tumor Biomarker Test Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.6 Japan Tumor Biomarker Test Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.7 Korea Tumor Biomarker Test Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.8 India Tumor Biomarker Test Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.9 Southeast Asia Tumor Biomarker Test Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.10 South America Tumor Biomarker Test Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 13.2 Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.1 Global Tumor Biomarker Test Consumption and Market Share by Regions 2019-2024
  • 13.2.2 Global Tumor Biomarker Test Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.3 China Tumor Biomarker Test Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.4 USA Tumor Biomarker Test Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.5 Europe Tumor Biomarker Test Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.6 Japan Tumor Biomarker Test Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.7 Korea Tumor Biomarker Test Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.8 India Tumor Biomarker Test Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.9 Southeast Asia Tumor Biomarker Test Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.10 South America Tumor Biomarker Test Sales, Sales Value and Growth Rate 2019-2024
• 13.3 Production (K Units), Revenue (M USD) by Types 2019-2024
  • 13.3.1 Overall Market Performance
  • 13.3.2 Prostate Specific Antigen Tests Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.3.3 CTC Tests Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.3.4 Alpha-Fetoprotein (AFP) Tests Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.3.5 CA Test Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 13.4 Sales by Application 2019-2024
  • 13.4.1 Overall Market Performance
  • 13.4.2 Lung cancer Sales and and Growth Rate 2019-2024
  • 13.4.3 Breast cancer Sales and and Growth Rate 2019-2024
  • 13.4.4 Colorectal Sales and and Growth Rate 2019-2024
  • 13.4.5 Prostate Cancer Sales and and Growth Rate 2019-2024
• 13.5 Price (USD/Unit) and Gross Profit
  • 13.5.1 Global Tumor Biomarker Test Price (USD/Unit) Trend 2019-2024
  • 13.5.2 Global Tumor Biomarker Test Gross Profit Trend 2019-2024

14 Conclusion

Geographically, global Tumor Biomarker Test market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Abbott Laboratories, Inc.
Agilent Technologies
AstraZeneca
Becton Dickinson & Co.
Biocept Inc.
Cancer Genetics Inc.
Danaher Corporation
Foundation Medicine Inc.
Illumina Inc.
LabCorp Of America Holdings
Luminex Corporation
Myriad Genetics Inc.
NanoString Technologies Inc.

On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
Prostate Specific Antigen Tests
CTC Tests
Alpha-Fetoprotein (AFP) Tests
CA Test
HER2 Tests
BRCA Test
Anaplastic Lymphoma Kinase (ALK) Tests
EGFR Mutation Tests
KRAS Test
Others
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Tumor Biomarker Test for each application, including
Lung cancer
Breast cancer
Colorectal
Prostate Cancer
Blood Cancer
HER2 Tests
BRCA Test
Anaplastic Lymphoma Kinase (ALK) Tests
EGFR Mutation Tests
KRAS Test
Others
Production, consumption, revenue, market share and growth rate are the key targets for Tumor Biomarker Test from 2013 to 2024 (forecast) in these regions
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

If you have any special requirements, please let us know and we will offer you the report as you want.